Poor glymphatic function is associated with mild cognitive impairment and its progression to Alzheimer's Disease: A DTI-ALPS Study - 03/04/25

Doi : 10.1016/j.tjpad.2025.100156 
Cuiping Bao 1, Hongbin Luo 2, Jao Wang 3, Xuehuan Liu 1, Yiming Li 1, Jun Yang 1, Chong Chen 4, Rongrong Yang 5, Weili Ba 1, Xinying Lian 6, Michelle Dunk 7, Jun Liu 6, 8, , Weili Xu 7
1 Department of Radiology, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, 300121, China 
2 Tianjin Jinnan District Center for Disease Control and Prevention, 28 Highway Road, Jinnan District, Tianjin 300350, China 
3 Department of Epidemiology, College of Preventive Medicine, Third Medical University, Chongqing 400038, China 
4 Department of Clinical Laboratory, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, 300121, China. 
5 Public Health Science and Engineering College, Tianjin University of Traditional Chinese Medicine, Tianjin, China. 
6 Tianjin Fourth Central Hospital, The Affiliated Hospital of Tianjin Medical University, Zhongshan Rord 1st Tianjin, 300140, China 
7 Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Skockholm, Sweden 
8 Tianjin Fourth Central Hospital, Tianjin University, Zhongshan Rord 1st Tianjin, 300140, China 

Corresponding to: Jun Liu, Tianjin Fourth Central Hospital, The Affiliated Hospital of Tianjin Medical University, Tianjin Fourth Central Hospital, Tianjin University, Zhongshan Rord 1st Tianjin, 300140, ChinaTianjin Fourth Central Hospital, The Affiliated Hospital of Tianjin Medical University, Tianjin Fourth Central HospitalTianjin UniversityZhongshan Rord 1stTianjin300140China

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Sous presse. Manuscrit accepté. Disponible en ligne depuis le Thursday 03 April 2025

Highlights

Low ALPS index was significantly associated with high risk of MCI, and the risk of MCI decreased linearly with a higher ALPS index
High ALPS index was dose-dependently associated with a decreased progression from MCI to AD
High ALPS index may delay the MCI onset about 3.8 years among CN participants and delay MCI progression to AD by 3.5 years in MCI group
Aβ in choroid plexus, tau in part of the cortex and executive function were partially mediate ALPS-AD association

Le texte complet de cet article est disponible en PDF.

Abstract

BACKGROUND

We aimed to explore the association between ALPS index and both risks of MCI from cognitively normal (CN) and incident AD progressed from MCI, as well as potential mediating factors.

METHODS

This study included 519 adults including 253 (48.75 %) CN and 266 (51.25 %) MCI participants from Alzheimer's Disease Neuroimaging Initiative. Glymphatic function (assessed by along the perivascular space [ALPS] index) was measured by diffusion tensor image at baseline. Neurobiomarkers (Aβ and tau from CSF, plasma and PET) and cognitive functions were served as mediators. Data were analyzed using Cox and Laplace regression and mediation analysis.

RESULTS

During follow-up (median 3.6 years, interquartile range [IQR]: 2.0 to 4.9 years), 30 (11.86%) participants developed MCI in the CN cohort and 73 (27.4%) participants progressed to AD in the MCI cohort. The hazard ratios (95% confidence intervals [CIs]) of the higher ALPS index was 0.605 (0.386–0.948) for MCI and 0.501 (0.356–0.706) for AD. In addition, participants with high ALPS index had 3.837 and 3.466 years prolonged onset of MCI and AD, separately. Aβ in choroid plexus (17.1%), tau in cortex [Inferiortemporal (21.1%), Middletemporal (AV1451:17.0%, FTP:15.5%, Superiortemporal(7.7%,), Meta_temporal (AV1451:17.5%, FTP:16.6%)], and executive function (14.1%) mediated the association between ALPS and MCI-AD progression.

CONCLUSION

High ALPS index decreases MCI risk and delays MCI progression to AD by 3.5 years. Aβ in choroid plexus, tau in cortex, and executive function may partially mediate the MCI-AD progression in relation to ALPS index.

Le texte complet de cet article est disponible en PDF.

Keywords : Glymphatic function, Along the perivascular spaces, Alzheimer's disease


Plan


© 2025  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.